Jesper Gromada

Active 1995–2023

80
Papers
19,217
Citations
72
h-index
80
i10-index

Citations

Citations per year for Jesper Gromada1991: 1 citations1994: 1 citations1996: 2 citations1997: 8 citations1998: 30 citations1999: 36 citations2000: 33 citations2001: 37 citations2002: 74 citations2003: 81 citations2004: 143 citations2005: 109 citations2006: 139 citations2007: 129 citations2008: 205 citations2009: 131 citations2010: 159 citations2011: 173 citations2012: 203 citations2013: 183 citations2014: 170 citations2015: 191 citations2016: 211 citations2017: 262 citations2018: 231 citations2019: 833 citations2020: 918 citations2021: 999 citations2022: 726 citations2023: 511 citations2024: 705 citations2025: 410 citations2026: 16 citations1992–1993: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,461 citing papers, 26% of this breakdownChina: 942 citing papers, 10% of this breakdownUnited Kingdom: 635 citing papers, 6.7% of this breakdownGermany: 538 citing papers, 5.7% of this breakdownCanada: 422 citing papers, 4.5% of this breakdownItaly: 353 citing papers, 3.7% of this breakdownSweden: 353 citing papers, 3.7% of this breakdownDenmark: 340 citing papers, 3.6% of this breakdownJapan: 299 citing papers, 3.2% of this breakdownAustralia: 257 citing papers, 2.7% of this breakdownFrance: 257 citing papers, 2.7% of this breakdownSwitzerland: 218 citing papers, 2.3% of this breakdown
0%26%Other 25.2%

Fields

  • Medicine61.2%
  • Biochemistry, Genetics and Molecular Biology30.8%
  • Immunology and Microbiology2.6%
  • Neuroscience2.4%
  • Nursing1.1%
  • Agricultural and Biological Sciences0.5%
  • Other1.4%

Topics

  • Pancreatic function and diabetes9.8%
  • Liver Disease Diagnosis and Treatment4.4%
  • Diabetes Treatment and Management4.1%
  • Fibroblast Growth Factor Research3.8%
  • Lipid metabolism and disorders3.2%
  • Diabetes and associated disorders3.1%
  • Other71.6%

Coauthors

All papers

Open in search
  1. A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott M. Damrauer, Daniel J. Rader, Brian Zambrowicz, William C. Olson, Andrew Murphy, Ingrid B. Borecki, Alan R. Shuldiner, Jeffrey G. Reid, John D. Overton, George D. Yancopoulos, Helen H. Hobbs, Jonathan C. Cohen, Omri Gottesman, Tanya M. Teslovich, Aris Baras, Tooraj Mirshahi, Jesper Gromada, Frederick E. Dewey - New England Journal of Medicine 2018 cited by 805

  2. RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes

    Authors: , , , , , , , , , - Cell Metabolism 2016 cited by 756

  3. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kae‐Woei Liang, Xiuqing Guo, Jerome I. Rotter, Yii‐Der I. Chen, William E. Kraus, Svati H. Shah, Scott M. Damrauer, Aeron Small, Daniel J. Rader, Anders Berg Wulff, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Anita M. van den Hoek, Hans M.G. Princen, David H. Ledbetter, David J. Carey, John D. Overton, Jeffrey G. Reid, William J. Sasiela, Poulabi Banerjee, Alan R. Shuldiner, Ingrid B. Borecki, Tanya M. Teslovich, George D. Yancopoulos, Scott Mellis, Jesper Gromada, Aris Baras - New England Journal of Medicine 2017 cited by 875

  4. FGF-21 as a novel metabolic regulator

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2005 cited by 2,089

  5. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2011 cited by 918

  6. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 510

  7. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 526

  8. Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance

    Authors: , , , , , , , , , , , , , , , - Journal of Lipid Research 2020 cited by 202

  9. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression

    Authors: , , , , , , , , , , , - Journal of Clinical Investigation 2017 cited by 339

  10. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis

    Authors: , , , , , , , - Hepatology 2014 cited by 374

  11. ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 329

  12. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance

    Authors: , , , , , , , , , , , , , - Journal of Lipid Research 2017 cited by 206

  13. Pseudotime Ordering of Single Human β-Cells Reveals States of Insulin Production and Unfolded Protein Response

    Authors: , , , , , , , , , - Diabetes 2018 cited by 201

  14. Activin A more prominently regulates muscle mass in primates than does GDF8

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 179

  15. ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys

    Authors: , , , , , , , , , , , , , , - Journal of Lipid Research 2015 cited by 212

  16. Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cassandra M. Hartle, Lukas Habegger, Samantha N. Fetterolf, Teresa Tusié‐Luna, Andrew P. Morris, Hilma Hólm, Valgerður Steinthórsdóttir, Patrick Sulem, Unnur Thorsteinsdottir, Jerome I. Rotter, Lee‐Ming Chuang, Scott M. Damrauer, David Birtwell, Chad M. Brummett, Amit V. Khera, Pradeep Natarajan, Marju Orho‐Melander, Jason Flannick, Luca A. Lotta, Cristen J. Willer, Oddgeir L. Holmen, Marylyn D. Ritchie, David H. Ledbetter, Andrew Murphy, Ingrid B. Borecki, Jeffrey G. Reid, John D. Overton, Ola Hansson, Leif Groop, Svati H. Shah, William E. Kraus, Daniel J. Rader, Yii‐Der Ida Chen, Kristian Hveem, Nicholas J. Wareham, Sekar Kathiresan, Olle Melander, Kāri Stefánsson, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Gonçalo R. Abecasis, David Altshuler, José C. Florez, Michael Boehnke, Mark I. McCarthy, George D. Yancopoulos, David J. Carey, Alan R. Shuldiner, Aris Baras, Frederick E. Dewey, Jesper Gromada - Nature Communications 2018 cited by 153

  17. The Liver–α-Cell Axis and Type 2 Diabetes

    Authors: , , , , , , , , , - Endocrine Reviews 2019 cited by 148

  18. Loss of ZnT8 function protects against diabetes by enhanced insulin secretion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason Flannick, Maddalena Trombetta, Enzo Bonora, Claes B. Wolheim, Leena Sarelin, Riccardo C. Bonadonna, Patrik Rorsman, Benjamin Davies, Julia Brosnan, Mark I. McCarthy, Timo Otonkoski, Jens O. Lagerstedt, Guy A. Rutter, Jesper Gromada, Anna L. Gloyn, Tiinamaija Tuomi, Leif Groop - Nature Genetics 2019 cited by 149

  19. Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol

    Authors: , , , , , , - Circulation Research 2019 cited by 63

  20. α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains

    Authors: , , - Endocrine Reviews 2007 cited by 577

  21. Clinical and Molecular Prevalence of Lipodystrophy in an Unascertained Large Clinical Care Cohort

    Authors: , , , , , , , , , , , , , , , , , - Diabetes 2019 cited by 95

  22. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion

    Authors: , , , , , - Journal of Lipid Research 2015 cited by 188

  23. The α-cell in diabetes mellitus

    Authors: , , - Nature Reviews Endocrinology 2018 cited by 145

  24. Hepatic ANGPTL3 regulates adipose tissue energy homeostasis

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 137